In:
Cancer Cytopathology, Wiley, Vol. 127, No. 5 ( 2019-05), p. 306-315
Abstract:
In this retrospective, international, multi‐institutional study, the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) has been applied to a cohort of 734 submandibular fine‐needle aspirates, and the risk of malignancy (ROM) has been calculated for each diagnostic category. The aspirates have been reclassified as follows: nondiagnostic, 21.4% (0%‐50%); nonneoplastic, 24.2% (9.1%‐53.6%); atypia of undetermined significance (AUS), 6.7% (0%‐14.3%); benign neoplasm, 18.3% (0%‐52.5%); salivary gland neoplasm of uncertain malignant potential (SUMP), 12% (0%‐37.7%); suspicious for malignancy (SM), 3.5% (0%‐12.5%); and malignant, 13.9% (2%‐31.3%). The histopathologic follow‐up is available for 333 cases (45.4%). The ROMs are as follows: nondiagnostic, 10.6%; nonneoplastic, 7.5%; AUS, 27.6%; benign neoplasm, 3.2%; SUMP, 41.9%; SM, 82.3%; and malignant, 93.6%. This study confirms that the MSRSGC can be reliably applied in reporting submandibular gland fine‐needle aspiration.
Type of Medium:
Online Resource
ISSN:
1934-662X
,
1934-6638
Language:
English
Publisher:
Wiley
Publication Date:
2019
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink